Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 236

1.

Genetic suppression of CRMP2 phosphorylation improves outcome in MPTP-induced Parkinson's model mice.

Togashi K, Hasegawa M, Nagai J, Tonouchi A, Masukawa D, Hensley K, Goshima Y, Ohshima T.

Genes Cells. 2018 Oct 29. doi: 10.1111/gtc.12651. [Epub ahead of print]

PMID:
30375127
2.

Modeling Complex Neurological Diseases with Stem Cells: A Study of Bipolar Disorder.

Pernia CD, Nathan NH, Tobe BTD, Winquist AM, Sidman RL, Goshima Y, Snyder EY.

Results Probl Cell Differ. 2018;66:265-282. doi: 10.1007/978-3-319-93485-3_12.

PMID:
30209664
3.

Inhibition of collapsin response mediator protein-2 phosphorylation ameliorates motor phenotype of ALS model mice expressing SOD1G93A.

Numata-Uematsu Y, Wakatsuki S, Nagano S, Shibata M, Sakai K, Ichinohe N, Mikoshiba K, Ohshima T, Yamashita N, Goshima Y, Araki T.

Neurosci Res. 2018 Sep 5. pii: S0168-0102(18)30499-1. doi: 10.1016/j.neures.2018.08.016. [Epub ahead of print]

PMID:
30194029
4.

Label-free and spectral-analysis-free detection of neuropsychiatric disease biomarkers using an ion-sensitive GaInAsP nanolaser biosensor.

Watanabe K, Nomoto M, Nakamura F, Hachuda S, Sakata A, Watanabe T, Goshima Y, Baba T.

Biosens Bioelectron. 2018 Oct 15;117:161-167. doi: 10.1016/j.bios.2018.05.059. Epub 2018 Jun 2.

PMID:
29894853
5.

Proteome and behavioral alterations in phosphorylation-deficient mutant Collapsin Response Mediator Protein2 knock-in mice.

Nakamura H, Takahashi-Jitsuki A, Makihara H, Asano T, Kimura Y, Nakabayashi J, Yamashita N, Kawamoto Y, Nakamura F, Ohshima T, Hirano H, Tanaka F, Goshima Y.

Neurochem Int. 2018 Oct;119:207-217. doi: 10.1016/j.neuint.2018.04.009. Epub 2018 May 11.

PMID:
29758318
6.

CRMP2-binding compound, edonerpic maleate, accelerates motor function recovery from brain damage.

Abe H, Jitsuki S, Nakajima W, Murata Y, Jitsuki-Takahashi A, Katsuno Y, Tada H, Sano A, Suyama K, Mochizuki N, Komori T, Masuyama H, Okuda T, Goshima Y, Higo N, Takahashi T.

Science. 2018 Apr 6;360(6384):50-57. doi: 10.1126/science.aao2300.

PMID:
29622647
7.

Human CRMP4 mutation and disrupted Crmp4 expression in mice are associated with ASD characteristics and sexual dimorphism.

Tsutiya A, Nakano Y, Hansen-Kiss E, Kelly B, Nishihara M, Goshima Y, Corsmeier D, White P, Herman GE, Ohtani-Kaneko R.

Sci Rep. 2017 Dec 1;7(1):16812. doi: 10.1038/s41598-017-16782-8.

8.

Regulation of axonal regeneration by the level of function of the endogenous Nogo receptor antagonist LOTUS.

Hirokawa T, Zou Y, Kurihara Y, Jiang Z, Sakakibara Y, Ito H, Funakoshi K, Kawahara N, Goshima Y, Strittmatter SM, Takei K.

Sci Rep. 2017 Sep 21;7(1):12119. doi: 10.1038/s41598-017-12449-6.

9.

L-DOPA sensitizes vasomotor tone by modulating the vascular alpha1-adrenergic receptor.

Masukawa D, Koga M, Sezaki A, Nakao Y, Kamikubo Y, Hashimoto T, Okuyama-Oki Y, Aladeokin AC, Nakamura F, Yokoyama U, Wakui H, Ichinose H, Sakurai T, Umemura S, Tamura K, Ishikawa Y, Goshima Y.

JCI Insight. 2017 Sep 21;2(18). pii: 90903. doi: 10.1172/jci.insight.90903. [Epub ahead of print]

10.

Structural basis for CRMP2-induced axonal microtubule formation.

Niwa S, Nakamura F, Tomabechi Y, Aoki M, Shigematsu H, Matsumoto T, Yamagata A, Fukai S, Hirokawa N, Goshima Y, Shirouzu M, Nitta R.

Sci Rep. 2017 Sep 6;7(1):10681. doi: 10.1038/s41598-017-11031-4.

11.

Protein Tyrosine Phosphatase δ Mediates the Sema3A-Induced Cortical Basal Dendritic Arborization through the Activation of Fyn Tyrosine Kinase.

Nakamura F, Okada T, Shishikura M, Uetani N, Taniguchi M, Yagi T, Iwakura Y, Ohshima T, Goshima Y, Strittmatter SM.

J Neurosci. 2017 Jul 26;37(30):7125-7139. doi: 10.1523/JNEUROSCI.2519-16.2017. Epub 2017 Jun 21.

12.

Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis.

Tobe BTD, Crain AM, Winquist AM, Calabrese B, Makihara H, Zhao WN, Lalonde J, Nakamura H, Konopaske G, Sidor M, Pernia CD, Yamashita N, Wada M, Inoue Y, Nakamura F, Sheridan SD, Logan RW, Brandel M, Wu D, Hunsberger J, Dorsett L, Duerr C, Basa RCB, McCarthy MJ, Udeshi ND, Mertins P, Carr SA, Rouleau GA, Mastrangelo L, Li J, Gutierrez GJ, Brill LM, Venizelos N, Chen G, Nye JS, Manji H, Price JH, McClung CA, Akiskal HS, Alda M, Chuang DM, Coyle JT, Liu Y, Teng YD, Ohshima T, Mikoshiba K, Sidman RL, Halpain S, Haggarty SJ, Goshima Y, Snyder EY.

Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4462-E4471. doi: 10.1073/pnas.1700111114. Epub 2017 May 12.

13.

A functional coupling between CRMP1 and Nav1.7 for retrograde propagation of Semaphorin3A signaling.

Yamane M, Yamashita N, Hida T, Kamiya Y, Nakamura F, Kolattukudy P, Goshima Y.

J Cell Sci. 2017 Apr 15;130(8):1393-1403. doi: 10.1242/jcs.199737. Epub 2017 Mar 2.

14.

CRMP4 Inhibits Bone Formation by Negatively Regulating BMP and RhoA Signaling.

Abdallah BM, Figeac F, Larsen KH, Ditzel N, Keshari P, Isa A, Jafari A, Andersen TL, Delaisse JM, Goshima Y, Ohshima T, Kassem M.

J Bone Miner Res. 2017 May;32(5):913-926. doi: 10.1002/jbmr.3069. Epub 2017 Feb 2.

15.

Axonal branching in lateral olfactory tract is promoted by Nogo signaling.

Iketani M, Yokoyama T, Kurihara Y, Strittmatter SM, Goshima Y, Kawahara N, Takei K.

Sci Rep. 2016 Dec 21;6:39586. doi: 10.1038/srep39586.

16.

Reduction and fragmentation of elastic fibers in the skin of obese mice is associated with altered mRNA expression levels of fibrillin-1 and neprilysin.

Makihara H, Hidaka M, Sakai Y, Horie Y, Mitsui H, Ohashi K, Goshima Y, Akase T.

Connect Tissue Res. 2017 Sep;58(5):479-486. doi: 10.1080/03008207.2016.1255205. Epub 2016 Nov 28.

PMID:
27892729
17.

CRMP1 and CRMP4 are required for proper orientation of dendrites of cerebral pyramidal neurons in the developing mouse brain.

Takaya R, Nagai J, Piao W, Niisato E, Nakabayashi T, Yamazaki Y, Nakamura F, Yamashita N, Kolattukudy P, Goshima Y, Ohshima T.

Brain Res. 2017 Jan 15;1655:161-167. doi: 10.1016/j.brainres.2016.11.003. Epub 2016 Nov 9.

PMID:
27836492
18.
19.

Glutamate Promotes Contraction of the Rat Ductus Arteriosus.

Fujita S, Yokoyama U, Ishiwata R, Aoki R, Nagao K, Masukawa D, Umemura M, Fujita T, Iwasaki S, Nishimaki S, Seki K, Ito S, Goshima Y, Asou T, Masuda M, Ishikawa Y.

Circ J. 2016 Oct 25;80(11):2388-2396. Epub 2016 Sep 21.

20.

l-3,4-Dihydroxyphenylalanine induces ptosis through a GPR143-independent mechanism in mice.

Ueda S, Masukawa D, Koga M, Goshima Y.

J Pharmacol Sci. 2016 Sep;132(1):109-112. doi: 10.1016/j.jphs.2016.08.005. Epub 2016 Aug 30.

21.

Comprehensive behavioral study and proteomic analyses of CRMP2-deficient mice.

Nakamura H, Yamashita N, Kimura A, Kimura Y, Hirano H, Makihara H, Kawamoto Y, Jitsuki-Takahashi A, Yonezaki K, Takase K, Miyazaki T, Nakamura F, Tanaka F, Goshima Y.

Genes Cells. 2016 Oct;21(10):1059-1079. doi: 10.1111/gtc.12403. Epub 2016 Sep 1.

22.

CRMP1 and CRMP2 have synergistic but distinct roles in dendritic development.

Makihara H, Nakai S, Ohkubo W, Yamashita N, Nakamura F, Kiyonari H, Shioi G, Jitsuki-Takahashi A, Nakamura H, Tanaka F, Akase T, Kolattukudy P, Goshima Y.

Genes Cells. 2016 Sep;21(9):994-1005. doi: 10.1111/gtc.12399. Epub 2016 Aug 2.

23.

Regulation of dendritic development by semaphorin 3A through novel intracellular remote signaling.

Goshima Y, Yamashita N, Nakamura F, Sasaki Y.

Cell Adh Migr. 2016 Nov;10(6):627-640. Epub 2016 Jul 8. Review.

24.

Gallic Acid, the Active Ingredient of Terminalia bellirica, Enhances Adipocyte Differentiation and Adiponectin Secretion.

Makihara H, Koike Y, Ohta M, Horiguchi-Babamoto E, Tsubata M, Kinoshita K, Akase T, Goshima Y, Aburada M, Shimada T.

Biol Pharm Bull. 2016;39(7):1137-43. doi: 10.1248/bpb.b16-00064.

25.

Caerulein-induced pancreatitis augments the expression and phosphorylation of collapsin response mediator protein 4.

Sato S, Nakamura F, Hiroshima Y, Nagashima Y, Kato I, Yamashita N, Goshima Y, Endo I.

J Hepatobiliary Pancreat Sci. 2016 Jul;23(7):422-31. doi: 10.1002/jhbp.361. Epub 2016 Jun 12.

PMID:
27207309
26.

MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma.

Hattori K, Sakata-Yanagimoto M, Okoshi Y, Goshima Y, Yanagimoto S, Nakamoto-Matsubara R, Sato T, Noguchi M, Takano S, Ishikawa E, Yamamoto T, Matsumura A, Chiba S.

Br J Haematol. 2017 May;177(3):492-494. doi: 10.1111/bjh.14080. Epub 2016 May 10. No abstract available.

PMID:
27161435
27.

Expression of receptor protein tyrosine phosphatase δ, PTPδ, in mouse central nervous system.

Shishikura M, Nakamura F, Yamashita N, Uetani N, Iwakura Y, Goshima Y.

Brain Res. 2016 Jul 1;1642:244-254. doi: 10.1016/j.brainres.2016.03.030. Epub 2016 Mar 26.

PMID:
27026654
28.

Deletion of Crmp4 attenuates CSPG-induced inhibition of axonal growth and induces nociceptive recovery after spinal cord injury.

Nagai J, Takaya R, Piao W, Goshima Y, Ohshima T.

Mol Cell Neurosci. 2016 Jul;74:42-8. doi: 10.1016/j.mcn.2016.03.006. Epub 2016 Mar 17.

PMID:
26995506
29.

Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.

Tonouchi A, Nagai J, Togashi K, Goshima Y, Ohshima T.

J Neurochem. 2016 Jun;137(5):795-805. doi: 10.1111/jnc.13617. Epub 2016 Apr 12.

30.

TrkA mediates retrograde semaphorin 3A signaling through plexin A4 to regulate dendritic branching.

Yamashita N, Yamane M, Suto F, Goshima Y.

J Cell Sci. 2016 May 1;129(9):1802-14. doi: 10.1242/jcs.184580. Epub 2016 Mar 4.

31.

Phosphorylation of CRMP2 by Cdk5 Regulates Dendritic Spine Development of Cortical Neuron in the Mouse Hippocampus.

Jin X, Sasamoto K, Nagai J, Yamazaki Y, Saito K, Goshima Y, Inoue T, Ohshima T.

Neural Plast. 2016;2016:6790743. doi: 10.1155/2016/6790743. Epub 2015 Dec 27.

32.

Inhibition of CRMP2 phosphorylation repairs CNS by regulating neurotrophic and inhibitory responses.

Nagai J, Owada K, Kitamura Y, Goshima Y, Ohshima T.

Exp Neurol. 2016 Mar;277:283-295. doi: 10.1016/j.expneurol.2016.01.015. Epub 2016 Jan 18.

PMID:
26795088
33.

Deletion of collapsin response mediator protein 4 results in abnormal layer thickness and elongation of mitral cell apical dendrites in the neonatal olfactory bulb.

Tsutiya A, Watanabe H, Nakano Y, Nishihara M, Goshima Y, Ohtani-Kaneko R.

J Anat. 2016 May;228(5):792-804. doi: 10.1111/joa.12434. Epub 2016 Jan 6.

34.

Voltage-gated calcium and sodium channels mediate Sema3A retrograde signaling that regulates dendritic development.

Yamashita N, Aoki R, Chen S, Jitsuki-Takahashi A, Ohura S, Kamiya H, Goshima Y.

Brain Res. 2016 Jan 15;1631:127-36. doi: 10.1016/j.brainres.2015.11.034. Epub 2015 Nov 27.

PMID:
26638837
35.

Quantitative analysis of intraneuronal transport in human iPS neurons.

Nakamura H, Yamashita N, Kanamaru Y, Tachibana T, Sekino Y, Chen S, Gotoh T, Tanaka F, Goshima Y.

J Pharmacol Sci. 2015 Aug;128(4):170-8. doi: 10.1016/j.jphs.2015.06.006. Epub 2015 Jun 27.

36.

Mouse pups lacking collapsin response mediator protein 4 manifest impaired olfactory function and hyperactivity in the olfactory bulb.

Tsutiya A, Nishihara M, Goshima Y, Ohtani-Kaneko R.

Eur J Neurosci. 2015 Sep;42(6):2335-45. doi: 10.1111/ejn.12999. Epub 2015 Jul 23.

PMID:
26118640
37.

Anti-Semaphorin 3A neutralization monoclonal antibody prevents sepsis development in lipopolysaccharide-treated mice.

Yamashita N, Jitsuki-Takahashi A, Ogawara M, Ohkubo W, Araki T, Hotta C, Tamura T, Hashimoto S, Yabuki T, Tsuji T, Sasakura Y, Okumura H, Takaiwa A, Koyama C, Murakami K, Goshima Y.

Int Immunol. 2015 Sep;27(9):459-66. doi: 10.1093/intimm/dxv014. Epub 2015 Apr 7.

PMID:
25855660
38.

Semaphorin 3A controls allergic and inflammatory responses in experimental allergic conjunctivitis.

Tanaka J, Tanaka H, Mizuki N, Nomura E, Ito N, Nomura N, Yamane M, Hida T, Goshima Y, Hatano H, Nakagawa H.

Int J Ophthalmol. 2015 Feb 18;8(1):1-10. doi: 10.3980/j.issn.2222-3959.2015.01.01. eCollection 2015.

39.

Crmp4 deletion promotes recovery from spinal cord injury by neuroprotection and limited scar formation.

Nagai J, Kitamura Y, Owada K, Yamashita N, Takei K, Goshima Y, Ohshima T.

Sci Rep. 2015 Feb 5;5:8269. doi: 10.1038/srep08269.

40.

Expression of ocular albinism 1 (OA1), 3, 4- dihydroxy- L-phenylalanine (DOPA) receptor, in both neuronal and non-neuronal organs.

Fukuda N, Naito S, Masukawa D, Kaneda M, Miyamoto H, Abe T, Yamashita Y, Endo I, Nakamura F, Goshima Y.

Brain Res. 2015 Mar 30;1602:62-74. doi: 10.1016/j.brainres.2015.01.020. Epub 2015 Jan 16.

PMID:
25601010
41.

Semaphorin3A-induced axonal transport mediated through phosphorylation of Axin-1 by GSK3β.

Hida T, Nakamura F, Usui H, Takeuchi K, Yamashita N, Goshima Y.

Brain Res. 2015 Feb 19;1598:46-56. doi: 10.1016/j.brainres.2014.12.028. Epub 2014 Dec 18.

PMID:
25528666
42.

IRE-1/XBP-1 pathway of the unfolded protein response is required for properly localizing neuronal UNC-6/Netrin for axon guidance in C. elegans.

Asakura T, Ogura K, Goshima Y.

Genes Cells. 2015 Mar;20(3):153-9. doi: 10.1111/gtc.12206. Epub 2014 Dec 2.

43.

Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis.

Takahashi K, Kurihara Y, Suzuki Y, Goshima Y, Tanaka F, Takei K.

JAMA Neurol. 2015 Feb;72(2):176-9. doi: 10.1001/jamaneurol.2014.3613.

PMID:
25437093
44.

Amino- and carboxyl-terminal domains of Filamin-A interact with CRMP1 to mediate Sema3A signalling.

Nakamura F, Kumeta K, Hida T, Isono T, Nakayama Y, Kuramata-Matsuoka E, Yamashita N, Uchida Y, Ogura K, Gengyo-Ando K, Mitani S, Ogino T, Goshima Y.

Nat Commun. 2014 Oct 31;5:5325. doi: 10.1038/ncomms6325.

PMID:
25358863
45.

Cardiovascular actions of DOPA mediated by the gene product of ocular albinism 1.

Goshima Y, Nakamura F, Masukawa D, Chen S, Koga M.

J Pharmacol Sci. 2014;126(1):14-20. Epub 2014 Sep 4. Review.

46.

Localization of ocular albinism-1 gene product GPR143 in the rat central nervous system.

Masukawa D, Nakamura F, Koga M, Kamiya M, Chen S, Yamashita N, Arai N, Goshima Y.

Neurosci Res. 2014 Nov;88:49-57. doi: 10.1016/j.neures.2014.07.008. Epub 2014 Aug 7.

PMID:
25108060
47.

LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand.

Kurihara Y, Iketani M, Ito H, Nishiyama K, Sakakibara Y, Goshima Y, Takei K.

Mol Cell Neurosci. 2014 Jul;61:211-8. doi: 10.1016/j.mcn.2014.07.001. Epub 2014 Jul 15.

PMID:
25034269
48.

Impaired nitric oxide production and increased blood pressure in systemic heterozygous ATP2B1 null mice.

Fujiwara A, Hirawa N, Fujita M, Kobayashi Y, Okuyama Y, Yatsu K, Katsumata M, Yamamoto Y, Ichihara N, Saka S, Toya Y, Yasuda G, Goshima Y, Tabara Y, Miki T, Ueshima H, Ishikawa Y, Umemura S.

J Hypertens. 2014 Jul;32(7):1415-23; discussion 1423. doi: 10.1097/HJH.0000000000000206.

PMID:
24805951
49.

Plexin-A4-dependent retrograde semaphorin 3A signalling regulates the dendritic localization of GluA2-containing AMPA receptors.

Yamashita N, Usui H, Nakamura F, Chen S, Sasaki Y, Hida T, Suto F, Taniguchi M, Takei K, Goshima Y.

Nat Commun. 2014 Mar 6;5:3424. doi: 10.1038/ncomms4424.

PMID:
24599038
50.

β-Cell proliferation after a partial pancreatectomy is independent of IRS-2 in mice.

Togashi Y, Shirakawa J, Orime K, Kaji M, Sakamoto E, Tajima K, Inoue H, Nakamura A, Tochino Y, Goshima Y, Shimomura I, Terauchi Y.

Endocrinology. 2014 May;155(5):1643-52. doi: 10.1210/en.2013-1796. Epub 2014 Feb 11.

PMID:
24517226

Supplemental Content

Loading ...
Support Center